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Repeated exposure to Group-A β-Haemolytic Streptococcus (GAS) may constitute a vulnerability 
factor in the onset and course of pediatric motor disturbances. GAS infections/colonization can 
stimulate the production of antibodies, which may cross the blood brain barrier, target selected 
brain areas (e.g. basal ganglia), and exacerbate motor alterations. Here, we exposed developing SJL 
male mice to four injections with a GAS homogenate and evaluated the following domains: motor 
coordination; general locomotion; repetitive behaviors; perseverative responses; and sensorimotor 
gating (pre-pulse inhibition, PPI). To demonstrate that behavioral changes were associated with 
immune-mediated brain alterations, we analyzed, in selected brain areas, the presence of infiltrates 
and microglial activation (immunohistochemistry), monoamines (HPLC), and brain metabolites 
(in vivo Magnetic Resonance Spectroscopy). GAS-exposed mice showed increased repetitive and 
perseverative behaviors, impaired PPI, and reduced concentrations of serotonin in prefrontal cortex, 
a brain area linked to the behavioral domains investigated, wherein they also showed remarkable 
elevations in lactate. Active inflammatory processes were substantiated by the observation of 
infiltrates and microglial activation in the white matter of the anterior diencephalon. These data 
support the hypothesis that repeated GAS exposure may elicit inflammatory responses in brain areas 
involved in motor control and perseverative behavior, and result in phenotypic abnormalities.
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A growing body of experimental and clinical evidence indicate that repeated infections may consti-
tute a vulnerability factor for the development or exacerbation of neuropsychiatric disorders entailing 
compromised motor function1,2. The potential relationship between streptococcal infection and move-
ment disorders has been observed in several cases of Tourette’s Syndrome (TS) and Sydenham chorea 
(SC)3. Cardona and Orefici observed remarkably higher levels of anti-streptococcal antibodies in a large 
cohort of TS patients compared to healthy controls4. Similarly, Rizzo and colleagues reported increased 
anti-streptococcal antibody titers in TS patients5, and Bombaci and collaborators reported that sera of 
patients with tic disorders exhibit immunological profiles typical of a broad, specific, and strong immune 
response against Group-A β -Haemolytic Streptococcus GAS6. An analogous pathogenic mechanism has 
been identified for SC, a neurological disorder characterized by involuntary movements associated with 
obsessive-compulsive symptoms and emotional liability7,8.
Concerning the potential link between peripheral infections and neurological disorders, several 
authors proposed that immunological adaptive responses towards specific pathogens might result, in 
vulnerable individuals, in maladaptive phenomena2,9. Specifically, antibodies produced in response to 
Streptococcus may, under conditions of increased permeability of the blood brain barrier, result in 
autoimmune responses directed toward specific brain targets9. In accordance with the observation of 
motor clinical symptoms, the molecular mimicry – and the resulting inflammatory processes – has 
been proposed to occur at the level of the basal ganglia, a brain structure directly involved in motor 
control2. Swedo and collaborators coined the acronym PANDAS to define these Pediatric Autoimmune 
Neuropsychiatric Disorders Associated with Streptococcal infections2,10. Dale and Brilot cogently dis-
cussed the possibility that autoimmune processes may occur more often in patients characterized by 
movement disorders than in the control population11.
Whilst streptococcal infections play a considerable role in exacerbating movement disorders, several 
other factors contribute to their etiology. Notwithstanding the presence of remarkable knowledge regard-
ing the pathophysiological mechanisms, the pharmacologic treatment of choice is still constituted by 
neuroleptics (e.g. haloperidol and pimozide) both in TS12–14 and SC15–17. Just as symptoms’ severity peaks 
during puberty, so also pharmacological therapy is given during this highly plastic stage of individual 
development. Thus, the possibility that current treatment strategies may beget enduring developmental 
side effects is considerably high13. Given the multifactorial etiology of these disorders and the paucity of 
therapeutic approaches, it is crucial to develop animal models of PANDAS upon which testing alternative 
hypotheses regarding the potential regulatory role exerted by genetic and environmental factors, and/or 
innovative therapeutic approaches18.
Repeated immunizations with GAS homogenate have been previously reported to result in the exhibi-
tion of motor alterations and in immunohistochemical abnormalities in mice19,20 and rats3,21. Specifically, 
Hoffman and colleagues showed that immunization of female mice with GAS homogenates resulted in 
increased rearing behavior and that these alterations were associated with IgG deposits in deep cerebellar 
nuclei19; Yaddanapudi and colleagues provided support to the autoimmune explanation of these data 
through a passive immunization study20. Thus, they showed that passive transfer of antibodies produced 
by GAS-treated mice resulted in behavioral and immunohistochemical abnormalities similar to those 
observed in response to active immunization20. Finally, Brimberg and collaborators reported that expo-
sure to GAS in rats resulted in behavioral manifestations reminiscent of SC, which were alleviated by 
the administration of haloperidol3.
Leveraging these studies, here we tested the hypothesis that repeated exposure to GAS may constitute 
a vulnerability factor in the onset of neurological motor disturbances22. To this aim, we exposed SJL 
mice to repeated subcutaneous injections with a GAS homogenate20 during development (between late 
infancy and young adulthood), and then evaluated their short- and long-term effects on the aforemen-
tioned behavioral domains. Although PANDAS occur in the pediatric population, technical constraints 
(see below for a detailed discussion) resulted in the necessity to evaluate the phenotypic alterations in 
young adult individuals. The relevance of the young maturational stage has been considered by beginning 
the injection protocol shortly after weaning. This study was aimed at extending existing literature3,19,20 
through the analysis of a wider spectrum of variables compared to those previously considered. Thus, 
here we investigated whether exposure of developing mice to GAS homogenates resulted in inflamma-
tory processes in several brain areas, we extended the analysis of brain parameters to magnetic resonance 
spectroscopy and neurochemistry, and performed a behavioral test battery encompassing most of the 
parameters often associated with PANDAS. Specifically, to address whether the phenotypic alterations 
were specific to repetitive behaviors and perseverative responding or generalized to other domains, we 
performed a series of tests evaluating general locomotion, motor coordination, anxiety, sensorimotor 
gating (pre-pulse inhibition, PPI) and stereotypies. To evaluate the functional state of core brain areas 
involved in PANDAS, we performed magnetic resonance spectroscopy (MRS) in the striatum and pre-
frontal cortex. In line with clinical data indicating that movement disorders are often associated with 
major alterations in brain monoamines23 and that PANDAS symptoms may be mitigated by the admin-
istration of selective serotonin reuptake inhibitors3,24,25 and dopaminergic antagonists26,27, we also meas-
ured concentrations of serotonin, dopamine, and their metabolites in hippocampus, striatum, prefrontal 
cortex, cerebellum and hypothalamus. The presence of GAS specific antibodies, in sera from mice repeat-
edly injected with GAS homogenates formulated in Freund’s or with adjuvant alone as negative control, 
was investigated by Western Blot analysis. Ultimately, to confirm a pathophysiological link between GAS 
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exposure and the presence of autoantibodies directed against brain targets, we performed histochemical 
and immunohistochemical assessment of the potential presence of inflammatory conditions linked to the 
experimental model examined in the current work, with particular attention to the identification of the 
specific types of immune-mediated responses.
Materials and Methods
Animals and rearing conditions. All the experiments were conducted between February and June, 
2013. Male SJL/J mice (post-natal day, (PND) 22) were purchased from Charles River, Italy (Calco, 
LC). Upon arrival, all mice (N = 100) were weighed and housed individually in standard polycarbonate 
cages (33.0 × 13.0 × 14.0 cm) with sawdust bedding and ad libitum water and food (Mucedola, Settimo 
Milanese, Italy). They were maintained in an air-conditioned room (temperature 21 ± 1 °C and relative 
humidity 60 ± 10%) with a reversed 12-h light-dark cycle (lights on at 19.00 h). All experimental pro-
cedures were performed in accordance with European Communities guidelines (EC Council Directive 
86/609), Italian legislation on animal experimentation (Decreto L.vo 116/92) and NIH guide for the care 
and use of laboratory animals. The study has been approved by the Service for Biotechnology and Animal 
Welfare of the Istituto Superiore di Sanità and authorized by the Italian Ministry of Health (Decree Nr. 
217/2010-B).
Immunization Protocol. GAS Homogenate Preparation. Group A Streptococcus (GAS) homogen-
ates used for mouse immunization procedure were prepared as described in19 and stored at − 70 °C. A 
sample of the homogenate (2.5 μ L) was used to inoculate a blood agar plate to verify that it contained 
no viable bacteria.
Active immunization of mice with GAS homogenates. The immunization protocol, which 
entailed four injections interspaced by three weeks, followed the procedure described by Hoffman 
et al.19 and Yaddanapudi et al.20. The first injection was performed on PND 28. Each mouse was assigned 
randomly to one of two groups: control (CTRL) group (N = 48) and GAS group (N = 48). During the 
primary injection, CTRL mice were treated subcutaneously (s.c.) with 125 μ L of an emulsion (1:1) con-
taining PBS and Complete Freund’s adjuvant (CFA; Sigma Aldrich, Milano, Italy). Mice in the GAS group 
(N = 48) received (s.c.) with 125 μ L of the same emulsion (CFA:PBS) containing 2.5 μ L of GAS homoge-
nate (0.52 mg/ml of total protein as determined by Bradford Assay, Biorad). All mice were then injected 
three additional times at 3-week intervals with 125 μ L of an emulsion of phosphate buffered saline (PBS) 
and Incomplete Freund’s adjuvant (IFA; Sigma Aldrich, Milano, Italy) alone for CTRL group, or 125 μ L of 
an emulsion (PBS:IFA) containing 2.5 μ L of GAS homogenate for GAS group. The immunization proto-
col was meant to replicate the procedures adopted in the original articles19,20 upon which our study rests. 
Thus, beside the preparation of the homogenate and the doses administered, the time of first injection 
and subsequent boosts are similar to those adopted in the original studies. Time of first injection in20 var-
ied between four and six weeks and subsequent boosts were administered at three-weeks intervals. In19, 
mice were first immunized at six weeks of age and then boosted three times at four or six-week intervals. 
To prepare the PBS/adjuvant emulsions we used the vortex method described by Flies and Chen28.
Blood (~100 μ l) was collected by tail incision 14 days after the primary injection and after the first 
and second boosts. After collection, whole blood was allowed to clot at room temperature for 4–6 hours, 
then centrifuged at 3.000 rpm for 15 minutes. The serum supernatant was transferred into Eppendorf 
tubes and stored at − 80 °C for the evaluation of antibodies.
Behavioral testing. The first test battery was administered to a group of mice (Batch I, 
N = 10 per group) one week after the primary immunization (week 5). An independent group of mice 
(Batch II, N = 10 per group) were screened for the same test battery one week after the second boost 
(week 11). For each test battery, mice performed five different behavioral tests in the following sequence: 
elevated 0-maze and dowel test on the first day; rotarod test and marble burying on the second day; 
and open-field on the last day. On the morning of the test, mice were moved to a behavioral testing 
room where they remained until the end of the daily test session. A group of 20 mice from the third 
batch (Batch III) were then screened for perseverative behaviors in a T-maze one week after the second 
boost (week 11). Finally, a separate group of individuals (Batch IV) were tested for sensory-motor gating 
through the evaluation of PPI. All data have been analyzed by trained personnel blind to treatments.
Elevated 0-Maze. To evaluate the exploration of an environment imposing on the animal an 
approach-avoidance conflict, mice were tested on the elevated 0-maze29, a 5.5 cm wide circular run-
way made of black plastic with an outer diameter of 46 cm, and placed 40 cm above the floor. Two 
opposing sectors were protected by 16 cm high walls made of Plexiglas (closed sectors), and the two 
remaining sectors were unprotected (open sectors). Mice underwent the test after 1 hour of acclimati-
zation in the experimental room between 11:00 and 15:00. The test was performed under dim lights. 
Each session lasted 5 minutes and started with the animal released in one of the closed sectors. Beside 
spatio-termporal variables (time spent and number of entries in each sector), the following behavioral 
responses were detected in frequency and duration: rearing, grooming, stretched attend posture, and head 
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dipping. Time spent in the open sectors was considered an inverse index of anxiety state while the total 
number of entries was used as a measure of general activity (see Ref. 29 for additional details).
Dowel test. This test requires animals to balance on an elevated hardwood round dowel30 and is gen-
erally used to investigate motor coordination on a static apparatus. The dowel (0.9 mm in diameter and 
35 cm long), covered with paper tape, was mounted horizontally 50 cm above the floor and fixed between 
two flat frames. A box filled with sawdust bedding was placed underneath the dowel to attenuate the 
fall. At the beginning of testing, each mouse was placed in the middle of the dowel so that the length of 
its body was parallel to the dowel. The time taken for the animal to fall from the dowel (latency to fall) 
was recorded. Cut-off time was 3 minutes. Each mouse was given three trials with 15 minutes intervals 
between them. Mice that walked across the dowel were assigned the cut-off time.
Accelerating rotarod test. The rotarod apparatus (Basile, Comerio, Italy) was used to evaluate the mouse 
balance and motor coordination measured by the latency to fall from the apparatus31. Differently from 
the Dowel, the rotarod test addresses individual coordination on a dynamic apparatus. Specifically, it 
consisted of a rotating cylinder (3 cm in diameter) on which the mouse had to continuously walk forward 
in order to avoid falling from the rod. The time spent on the rod was automatically recorded by a timer 
connected to a switch that stopped when the mouse fell. Two mice were tested simultaneously. Each 
mouse was given three trials with the rate of rotation of the rod increasing from 4 to 40 revolutions per 
minute (r.p.m.) over 4 minutes. Trials were interspaced by 10-min intervals. The trial ended when the 
mouse fell from the rod or reached the cut-off time (4 min). The falling latency averaged over three trials 
has been used as the dependent variable
Marble burying. The marble burying assay is often used as an indicator of anxiety-like behavior and/
or obsessive-compulsive like behaviors32,33. Specifically, although initial burying episodes may connote a 
natural tendency exhibited by control animals, persistent burying bouts have been proposed to represent 
compulsive stereotypies dependent on a “frustrated investigation of the non-reactive stimulus-object”32. 
Testing was performed in standard polycarbonate cages (33.0 × 13.0 × 14.0 cm) filled with a 5-cm layer 
of sawdust bedding and covered with a wire mesh cage top without food and water. Twelve glass marbles 
(14 mm diameter) were evenly spaced in two rows on the bedding surface. Mice were placed individually 
in the cages and left undisturbed for a 30-min testing period. At the end of the test, each mouse was 
removed and the number of buried marbles was counted. A marble was considered buried when more 
than two-thirds of its surface was covered with bedding.
Open-field test. To evaluate exploratory activity and general locomotion, mice were tested in the open 
field. The apparatus consisted of a square arena (60 × 60 cm) with 60 cm high walls made of grey plastic. 
The floor of the apparatus was subdivided in 6 × 6 matrix (each square was 10 × 10 cm). A central square 
(20 × 20 cm) was drawn in the middle of the open field to delimitate the central area of the arena. The 
maze was located in the experimental room and lit by a 60-watt lamp for background lighting.
The test started by placing the mouse in one corner of the arena and lasted 45 min. The open field was 
cleaned between each session using 10% ethanol/water solution. The activity of mice during the test was 
video recorded with a video camera suspended from the ceiling. The behaviors expressed during the first 
and last five minutes of recording were subsequently scored by a trained observer using a computer with 
dedicated software (The Observer 2.0, Noldus Information Technology, Wageningen, The Netherlands). 
The behavioral responses scored included: line crossing, rearing, sniffing, grooming, and immobility. Each 
animal was given a score for total locomotor activity that was calculated as the sum of line crossings. 
Time spent in the central area of the arena was also measured as an inverse index of anxiety.
T-Maze. A third subset of animals (Batch III, N = 9–10 per group) was screened for perseverative 
behavior in the T-Maze. This test is traditionally used to investigate perseverative responses in laboratory 
rodents through the evaluation of two consecutive choices in a paradigm in which subjects are given two 
alternatives. While control subjects generally exhibit spontaneous alternations, perseverative individuals 
display an elevated rate of consecutive identical responses. The apparatus was an enclosed maze with 
the form of a T consisting of three arms of equal size (50 × 16 cm). The test was performed in the room 
where the animals were housed and comprised 10 trials performed during five consecutive days. In each 
session the mouse was placed in the starting compartment facing the wall of the apparatus. The mouse 
was allowed to explore the apparatus for 2 minutes. As soon as the animal entered (with all four paws) 
one of the two alternative arms (left or right) the door of that compartment was closed and that arm was 
indicated as the first choice of the animal. After few seconds, the animal was gently removed from the 
maze and replaced in the starting compartment to perform a second choice trial. Mice generally alternate 
their choice of goal arm on the second trial if it is performed shortly after the first one, a behavior called 
‘spontaneous alternation’34. The percentage of arm alternations was recorded for each mouse.
Pre-pulse inhibition (PPI). PPI is traditionally adopted to evaluate sensorimotor gating capabilities in 
mammals through the analysis of the reduction in startle response produced by the presentation of a 
prepulse35. The experimental apparatus (med associates inc. St Albans, VT, United States of America, 
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see36 for details) was constituted by a platform with a transducer amplifier (PHM-250–60) and an acous-
tic stimulator (ANL-925). The apparatus was positioned in a foam-lined isolation chamber (ENV-018S). 
Dimmed lighting and ventilation were guaranteed by a red light and a fan positioned inside the chamber. 
To ensure that the experimental subjects remained on the platform, the latter was enclosed in a perforated 
compartment. Experimental data were acquired and analyzed through dedicated software (SOF-815).
Procedure: For habituation, mice were individually placed in the startle chamber and left undisturbed for 
5 minutes. On the following day, mice were positioned inside the startle chamber and exposed to a continu-
ous white noise (62 dB) for 5 minutes; following this acclimation, mice were exposed to 10 pulses of 120 dB 
interspaced by an average inter-trial interval of 15 seconds. Finally, an 8-min session started, consisting of 
28 trials. Each trial started with a 50-ms null period, followed by a 20-ms pre-pulse noise burst of 67, 70, 
73 or 76 dB. The delay between the pre-pulse and the startle (40-ms 120 dB white noise) was 100-ms. The 
experiment entailed the following types of trial: pre-pulse plus startle (four trials per pre-pulse intensity), 
prepulse alone (four trials per pre-pulse intensity), startle alone (four trials) and no stimulation (four tri-
als). To prevent habituation, the inter-trial interval varied between 10 and 20 seconds. Galvanic response 
(dependent variable) was measured every millisecond for 65 ms after the onset of the startle. Pre-pulse 
inhibition was measured as: PPI = [(A − B)/A]*100, wherein A is the baseline Galvanic reflex in response 
to the startle stimulus alone, and B is the reflex in response to the startle in pre-pulse plus startle trials.
Experimental design. The general experimental design entailed mice to be exposed to repeated 
behavioral testing, Magnetic Resonance Spectroscopy, blood sampling, and neurochemical and immu-
nohistochemical assays. To avoid pseudo-replications and distribute mice across the different dependent 
measurements, while maintaining an elevated statistical power, we formed four independent batches of 
mice: batch I, comprising 10 GAS-treated (four subcutaneous injections interspaced by three weeks) and 
10 control mice treated with Adjuvant alone (control group, hereafter CTRL); batch II, comprising 15 
GAS-treated and 15 CTRL mice; batch III, comprising 15 GAS-treated and 15 CTRL mice; and batch 
IV, comprising eight GAS-treated and eight CTRL mice. To avoid potential litter effects, littermates were 
attributed to different test procedures.
Attribution of batches to experimental testing was designed as follows (see also Fig. 1):
Batch I comprised a total number of 20 animals (N = 10 per group) which encountered behavioral 
tests (elevated 0-maze, dowel test, rotarod test, marble burying, and open-field see below for details) and 
Magnetic Resonance Spectroscopy (MRS) analyses;
Batch II comprised 30 mice (N = 15 per group); 20 mice (N = 10 per group) encountered the same test 
battery of the batch I after the second boost; they were then sacrificed one week and four weeks after 
Figure 1. Experimental design. Timing of the injections expressed in weeks, and the test procedures 
performed on the four independent batches of mice. Animals received 4 doses of GAS homogenate, 
prepared as described in the Methods section, or Phosphate Buffer Saline (PBS), formulated with the 
indicated adjuvants (CFA = Complete Freund’s adjuvant; IFA = Incomplete Freund’s adjuvant).
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the third boost for monoamine analyses of specific brain areas (N = 5 per group) and brain IgG deposits 
evaluation and immunohistochemistry (N = 5 per group), respectively.
Batch III comprised a total number of 30 mice. We collected blood at different time points from 
10 mice (N = 5 per group) for antibodies evaluation. A subset of animals, for a total number of 20 mice 
(N = 10 per group) was tested in a T-Maze to measure perseverative behavior.
Batch IV comprised a total number of 16 mice, which were used only for the analysis of pre-pulse 
inhibition (N = 8 per group), following the third boost.
Magnetic resonance spectroscopy (MRS). After the first boost, a group of mice (batch I, 
n = 7 per group; see Fig.  2) between 8 and 9 weeks of age underwent MRS analyses, with the aim of 
measuring the concentration of biochemical parameters in prefrontal cortex and striatum (see also37). 
All experiments were conducted on a 4.7 T Varian Inova animal system (Varian/Agilent Inc. Palo Alto, 
CA, USA), equipped with actively shielded gradient system (max 200 mT/m, 12 cm bore size) and a 
combination of volume coil for transmission and a surface coil as receiver (Rapid Biomedical, Rimpar, 
Germany). Further details on the apparatus are described in38. Single voxel localised 1H MR spectra 
(PRESS, TR/TE = 4000/23 ms, ns = 256 or 512) were collected from relevant brain areas: prefrontal cor-
tex (PFC, 9.7 μ l) and striatum (STR, 9.7 μ l) (see Fig. 2). Quantitative MRS protocol, including water T2 
measurements, was applied, see39 for details.
Spectra were analysed using LCModel40 that calculates the best fit to the experimental spectrum as a 
linear combination of model spectra (spectra of metabolite solutions). Further details on the methodol-
ogy are described in Supplementary Information and in38.
Brain sampling. For brain sampling, mice were rapidly decapitated; brains were removed and further 
processed for the subsequent analyses. Brain samples for immunohistochemical analyses were flash fro-
zen and stored at − 80 °C. Samples for evaluation of brain monoamines by HPLC analyses were immedi-
ately sectioned on ice to obtain prefrontal cortex, striatum, hippocampus, hypothalamus, and cerebellum 
sections. All samples were immediately flash frozen, and then stored at − 80 °C until analysis.
Immunohistochemistry. Brain samples have been collected after the third boost (week 14) from 
five GAS and five CTRL mice and immediately frozen in isopentane on dry ice. Coronal cryosections 
(10 μ m thickness) were cut from whole brains and stored at − 80 °C. Haematoxylin and eosin staining 
was performed on all the examined brain samples (1 cryosection every 15 cut cryosections) in order 
to assess the presence of potential inflammatory infiltrates. For immunohistochemistry assessment of 
level of microglia activation, air dried cryosections were passed in 70%, 95% and 100% ethanol, and 
after rehydratation with PBS and 20-min incubation with 0.3% H2O2 in PBS to eliminate endogenous 
peroxidase activity, sections were pre-incubated with 10% of normal donkey serum and incubated at 
4 °C overnight with rabbit polyclonal antibody IBA1 (Wako-Chem, Japan) diluted in PBS containing 
5% normal donkey serum, followed by incubation with biotinilated donkey anti-rabbit secondary anti-
body (Jackson Immunoresearch Laboratories, Suffolk, UK) visualized with the avidin-biotin horserad-
ish peroxidase complex (ABC Vectastain Elite kit, Vector Laboratories, Burlingame, CA, USA) and 3,3 
diaminobenzidine (Sigma Chemical, St. Louis, MO, USA). All sections were counterstained with haema-
toxylin, sealed with Canada balsam and viewed and photographed with an Axiophot Zeiss microscope 
(Germany) equipped with an Axiocam digital camera using the Axiovision 4 AC software. For immu-
nofluoerescence, air-dried sections were pre-incubated with 10% of normal rabbit serum and incubated 
at 4 °C overnight with rat anti-mouse CD3 (Serotec, Oxford, UK) or anti-CD45R/B220 (Pharmingen, 
San Diego, CA, USA) antibodies, for T and B lymphocyets respectively, diluted in PBS containing 5% 
normal rabbit serum, followed by incubation with TRITC coniugated rabbit anti-rat secondary antibody 
(Jackson). Sections were sealed in ProLong Gold antifade reagent with 4’,6-diamidino-2-phenylindole 
(DAPI) (Invitrogen, Waltham, MA, USA), for the nuclei localization, and images were acquired and ana-
lysed with a Leica DM-4000B Microsystems microscope (Germany). Qualitative analysis of the presence 
and distribution of inflammatory cells was performed by a trained observer who did not perform the 
cutting (R.M.) blind to treatment across all the different brain areas.
Monoamine measurements. Concentration of 5-HT, DA and their metabolites, i.e. 5-hydroxyindole 
acetic acid (5-HIAA), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), were 
quantified by a modified method of HPLC combined with electrochemical detector (EC) as previously 
described41. Briefly, each brain region was weighed and a measured volume (10% W/V) of 0.1 N per-
chloric acid containing 0.05% Na2S2O5 and 0.1% Na2EDTA was added. The tissue was then disrupted by 
ultrasonication, centrifuged (10,000 × g; 5 minutes), and 100 μ l of the supernatant were removed and fil-
tered through 0.45 μ m PVDF syringe filters (Perkin-Elmer, Italy). Aliquots of 20 μ l were injected directly 
onto HPLC/EC system by a refrigerated (5 °C) autosampler (MIDAS, Spark-Holland, The Netherlands) 
for the separation of 5-HT, DA, 5-HIAA, DOPAC, and HVA through a Supelcosil LC-18DB, 3 μ m 
(75 × 3.0 mm) analytical column (Supelchem, Italy), thermostated at 40 °C. The mobile phase consisted 
of sodium acetate anhydrous (5 g/L), citric acid (4.5 g/L), sodium octan sulphonate (100 mg/L), Na2EDTA 
dihydrate (112 mg/L); CH3OH 7%. Monoamines and metabolites were measured by a Coulochem II 
electrochemical detector (Dionex, Switzerland) equipped with a 5011 electrochemical cell (E1 and E2 
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potentials were 0 and + 350 mV, respectively). A data system (Azur 4.6, Datalys, France) was used to 
calculate the concentration of analytes based on calibration curves prepared daily with appropriate con-
centrations of pure standards.
Analysis of anti-Group A Streptococcal antibodies in serum samples. GAS homogenates 
obtained as described above were size-separated by SDS-PAGE (4–12% acrylamide) under reducing 
Figure 2. The upper part of the image represents the position of the two voxels on the Prefrontal 
cortex (PFC) and Striatum (STR) of sagittal anatomical images. The lower image is an example of the 
spectrum obtained from the analysis of the striatum (black trace) with overimposed the LCModel fit (red 
trace); it indicates the concentrations (ppm) of various metabolites. Metabolites which are included in the 
basis set: creatine (Cr), glutamate (Glu), glutamine (Gln), myo-inositol (Ins), lactate (Lac), N-acetylaspartate 
(NAA), N-acetylaspartylglutamate (NAAG), phosphocreatine (PCr), and taurine (Tau). Lipids (Lip) and 
macromolecules (MM) were also included in the basis set.
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conditions and electroblotted onto nitrocellulose membranes. Immunostaining was performed by block-
ing the membrane overnight with 3% (w/v) skimmed milk in TPBS (0.1% Tween in PBS) and incubating 
for 2 h with sera from CTRL mice treated with adjuvant alone and from GAS-treated mice (all sera were 
diluted 1: 200). After 3 washes with TPBS, the membrane was incubated with HRP-conjugated second-
ary antibody (1:1000), washed again with TPBS and PBS, and developed with a chromogenic substrate.
Statistical analysis. All statistical analyses were conducted using the software Statview 5.0 (Abacus 
Concepts, USA). Since the experimental design entailed two groups of independent observations (CTRL 
and GAS subjects), experimental data have been analyzed through t-test for independent samples (i.e. 
analysis of variance – ANOVA – for two groups). Situations in which repeated observations were col-
lected on the same subjects were analyzed through repeated measures ANOVA for split-plot designs. 
Thus, group comparisons of the behavioral responses in elevated 0-Maze test and in T-maze were per-
formed using t-test, with treatment (CTRL vs GAS) as the between-subjects factor. The statistical model 
for Dowel test, rotarod test and Marble Burying was as follows: 2 treatments (CTRL vs GAS) × 3 trials 
(first, second, third) with treatment as the between-subjects factor and trial as the within-subjects fac-
tor; to investigate the effects of repeated immunizations the general model was: 2 treatments (CTRL 
vs GAS) × 2 sessions (week 5 vs week 11). Additionally, in the Dowel test, to evaluate the performance 
before and after the treatment, we also performed a t-test on the difference in falling latency exhibited 
on week 5 and week 11. The statistical model for open field was: 2 treatments (CTRL vs GAS) × 2 time 
bins (first and last five minutes). PPI data were analyzed through repeated measures ANOVA, wherein 
treatment (CTRL vs GAS) constituted a between subject factor and prepulse intensities (67, 70, 73 and 
76 dB) a within-subjects factor. In the MRS analysis, we applied a t-test with treatment (CTRL vs GAS) 
as between-subjects factor for the analysis of each metabolite in each specific brain area. Mann-Whitney 
U-tests were used in situations in which ANOVA assumptions were not met. Brain monoamines were 
analyzed through one-tailed T-tests with treatment (CTRL vs GAS) as between-subject factor. Finally, 
immunohistochemical observations – qualitatively measured as presence or absence of infiltrates and 
microglial activation – were analyzed through Chi-square tests. Fisher’s protected least-significance dif-
ference (PLSD) test was used for post-hoc comparisons. The relationship between behavioral data and 
brain neurochemistry (5-HT concentration in hippocampus and 5-HIAA/5-HT turnover in cerebellum) 
was investigated through simple regression analysis. Data are always expressed as mean ± SEM. Statistical 
significance was set at p < 0.05.
Results
Evaluation of anti-GAS antibody responses in sera from mice treated with GAS homogen-
ates. To investigate the presence of GAS-specific antibodies in sera from treated mice, 10 μ l of GAS 
homogenates were loaded onto SDS-PAGE, transferred to nitrocellulose, and tested with pools of sera 
from animals injected with one or four doses of GAS homogenates or adjuvant alone. As expected, 
Coomassie stained lanes displayed a complex pattern of proteins, typical of GAS homogenates (Fig.  3, 
lane 1). Western Blot analysis of these extracts using sera from animals treated with one dose of GAS 
homogenate or adjuvant alone did not reveal any band (Fig. 3, lanes 2 and 3 respectively). Several bands 
were instead detected in the lane incubated with sera from animals receiving 4 doses of GAS homogen-
ates, but not with four doses of adjuvant alone (Fig. 3, lanes 4 and 5 respectively). The pattern in lane 4 
pattern reflected the Comassie stained pattern of lane 1, except that only a subset of the bands present in 
lane 1 were also present in lane 4. In particular, we observed 1 faint band above 98 Kda, 4–5 faint bands 
between 62 and 98 kDa, 1–2 main bands just below 62 kDa, 2 of about 49 kDa, 1 between 28 and 38 kDa, 
and 1 between 28 and 17 kDa. The results indicate that sera from GAS treated mice recognized some of 
the proteins present in the GAS homogenate.
Body weight gain. To evaluate whether repeated GAS injections resulted in differences in growth 
curves, we evaluated individual body weight gain throughout the entire experiment. We observed that 
CTRL and GAS mice showed an indistinguishable body weight gain throughout the study (treatment: 
F(1, 39) = 0.04, p = 0.9, data not shown).
Elevated 0-Maze (E0M) test (week 5, first injection and week 11, boost 2). We evaluated the 
behavioral profile of naïve subjects on the E0M test after both the first injection (week 5) and the second 
boost (week 11). Average values and standard errors of all observed data are reported in the supplemen-
tary material (see Table 1SM). As expected, experimental subjects showed a remarkable preference for 
the closed than the open sectors of the maze, whereby they spent approximately 85% of their time in the 
former and 15% in the latter. Following the first injection, CTRL and GAS mice did not show significant 
differences in general locomotion (frequency of entries, treatment: F(1,18) = 0.01, p = 0.93), time spent 
in the open arms (treatment: F(1,18) = 0.01, p = 0.91), and the ethological measures considered (duration 
of rearing, treatment: F(1,18) = 3.6, p = 0.07; frequency of head dipping, treatment: F(1,18) = 0.2, p = 0.7; 
frequency of SAP, treatment: F(1,18) = 0.4, p = 0.5; grooming, treatment: F(1,18) = 0.2, p = 0.6). Yet, fol-
lowing the second boost, while all mice spent almost the same amount of time in the open arms (11–12% 
of the single 5-minutes session, treatment: F(1,18) = 0.09, p = 0.8), GAS mice spent more time rearing 
compared to CTRL mice (treatment: F(1,18) = 4.54, p = 0.04, see Fig. 4). We did not observe significant 
www.nature.com/scientificreports/
9Scientific RepoRts | 5:13257 | DOi: 10.1038/srep13257
Figure 3. Western Blot analysis of GAS extracts probed with pooled sera from mice treated with GAS 
or with Adjuvant as Control. Lane 1, Coomassie staining of GAS homogenates; lane 2, Western Blot results 
after probing with sera of mice injected with one dose of GAS homogenates from GAS treated mice; lane 3, 
Western Blot results after probing with sera of control mice injected with one dose of Adjuvant alone; lane 4, 
Western Blot results after probing with sera of mice injected with four doses of GAS homogenates from GAS 
treated mice; lane 5, Western Blot results after probing with sera of Control mice injected with four doses of 
Adjuvant alone.
Figure 4. Rearing behavior in the elevated 0-maze (week 11, boost 2). The graph shows the duration of 
rearing behavior (s) in the elevated 0-maze during a 5-minutes long test session performed after the second 
boost (week 11). GAS mice significantly differ from CTRL mice. *p < 0.05. N = 10 per group.
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between-group differences in the other behavioral parameters considered (frequency of head dipping, 
treatment: F(1,18) = 1.0, p = 0.3; frequency of SAP, treatment: F(1,18) = 1.5, p = 0.2).
Dowel test (week 5, first injection and week 11, boost 2). Following the first injection, compared 
to CTRL mice, GAS individuals spent more time on the dowel (treatment: F(1,18) = 5.3, p = 0.03). The 
overall performance of CTRL and GAS mice declined with time: thus, following the second boost, all 
subjects showed a shorter fall latency than that observed following the first injection (time: F(1,18) = 14.0, 
p = 0.001). However, the decline in performance was more pronounced in GAS than in CTRL mice 
(p < 0.05 in post-hoc tests, see Fig. 5).
Rotarod test (week 5, first injection and week 11, boost 2). All mice showed a general decline 
in motor coordination on the rotarod between the first injection and the second boost. Thus, all 
mice showed a shorter falling latency on week 11 than on week 5 (time: F(1,18) = 18.2, p = 0.0005). 
Additionally, CTRL and GAS mice showed an indistinguishable performance on the rotarod follow-
ing both the first immunization (treatment: F(1,18) = 0.18, p = 0.68) and the second boost (treatment: 
F(1,18) = 0.4, p = 0.6, data not shown).
Marble Burying (week 5, first injection and week 11, boost 2). CTRL and GAS mice buried an 
indistinguishable number of marbles following both the first injection (treatment: F(1,18) = 1.8, p = 0.2; 
treatment × time: F(2,36) = 1.5, p = 0.2) and the second boost (treatment: F(1,18) = 0.05, p = 0.8; treat-
ment × time: F(2,36) = 0.4, p = 0.7). However, the number of marbles covered on week 11 were remark-
ably higher than those covered on week 5 (time: F(1,18) = 8.6, p = 0.009). Specifically, during the first 
test battery CTRL mice covered 4 ± 0.7 marbles and GAS mice covered 2.9 ± 0.5 marbles. On week 11, 
CTRL mice covered 7.5 ± 1 marbles and GAS mice covered 8.3 ± 0.7.
Open-field (week 5, first injection and week 11, boost 2). Following the first injection, CTRL 
and GAS mice showed an indistinguishable performance on the open field test. Specifically, they spent 
a similar amount of time in the centre of the arena (treatment: F(1,18) = 0.019, p = 1.0), they showed 
indistinguishable levels of general locomotion (frequency of crossing, treatment: F(1,18) = 0.01, p = 0.9) 
and of rearing and grooming behavior (treatment: F(1,18) = 0.005, p = 0.9; and treatment: F(1,18) = 1.4, 
p = 0.3; respectively).
Following the second boost (week 11), compared to CTRL group, GAS mice showed a differential 
behavior on the open field. Thus, in the absence of major differences in absolute levels of locomotion 
(treatment: F(1,18) = 0.9, p = 0.4), during the first five minutes of testing, GAS mice spent remarkably 
less time in the center square of the arena compared to CTRL group (time: F(1, 18) = 290.1, p < 0.0001; 
treatment: F(1, 18) = 4.4, p = 0.05, see Fig.  6, left panel). During the last five minutes of the test ses-
sion, GAS mice spent more time rearing compared to CTRL mice (treatment: F(1, 18) = 4.7, p = 0.04, 
see Fig. 6, right panel). Finally, irrespective of treatment (treatment: F(1,18) = 1.3, p = 0.3), all subjects 
spent more time grooming during the last five minutes of observation than during the first (time: F(1, 
18) = 100.1, p < 0.0001).
Figure 5. Motor coordination abilities in the dowel test. Falling latency (s) from a dowel covered with 
paper tape after the first injection (week 5) and the second boost (week 11). Histograms represent the 
average of three consecutive trials interspaced by 15-min intervals. *p < 0.05 in post-hoc tests between PBS 
and CTRL subjects; $p < 0.05 significantly different from GAS mice in post-hoc tests performed between 
data observed on week 5 and week 11. N = 10 per group.
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T-Maze. The percentage of arm alternations was calculated as an inverse measure of perseverative 
behavior. GAS mice showed a significantly lower percentage of alternations compared to CTRL mice 
(treatment: F(1,17) = 11.0, p = 0.004, see Fig. 7).
Pre-pulse inhibition. All subjects showed a reduced startle reflex in response to the pre-pulse 
plus pulse trials than to pulse alone. The percentage inhibition varied between groups (treatment: 
F(1,14) = 5.4, p = 0.036) with GAS individuals displaying reduced PPI compared to control individuals 
(see Fig.  8). Additionally, the different pre-pulse intensities induced a differential response (prepulse 
intensity: F(3,42) = 3.8, p = 0.016), with 67 dB eliciting the lowest response compared to the 70, 73, and 
76 dB. However, this differential response was similar in CTRL and GAS individuals (treatment × pre-
pulse intensity: F(3,42) = 0.57, p = 0.64). Ultimately, the two groups showed an analogous response to 
the pulse-alone trials (treatment: F(1,14) = 2.4, p = 0.143).
Magnetic resonance spectroscopy. 1H MRS analyses at 4.7 T detected a few differences in the spec-
tra acquired in the striatum and the PFC between CTRL and GAS mice (see Fig.  9). The quantitative 
results of all metabolite concentrations are reported in Fig. 9. In the striatum, we observed that GAS mice 
exhibited increased levels of the glutamate + glutamine pool (Glu + Gln) (F(1,10) = 13.4, p = 0.004). In 
the PFC, the analysis of the concentration of lactate revealed that GAS group had a remarkably high 
concentration of this metabolite compared to CTRL group. With respect to the latter, lactate was not 
quantifiable in any of the subjects tested. For this reason, we performed a non-parametric statistical 
analysis which revealed a significant difference between GAS and CTRL individuals (Chi2 = 3.48, N = 10, 
p < 0.01).
Analysis of brain monoamines. The data regarding concentrations of monoamines and their metab-
olites in selected brain areas are reported in the supplementary material (see Table 2SM). We observed 
significant differences in serotonergic transmission in PFC and cerebellum. Thus, compared to CTRL, 
Figure 6. Open-field (week 11, boost 2). (left) Time spent in the center of the arena during the first and 
last five minutes of session recording; (right) duration of rearing behavior during the first and last five 
minutes of session recording; *p < 0.05 in post-hoc tests; N = 10 per group.
Figure 7. Spontaneous alternation in a T-maze (week 11, boost 2). Percentage of spontaneous alternations 
following the second boost (week 11). Values are expressed as mean ± SEM. **p < 0.01. N = 10, CTRL group; 
N = 9, GAS group.
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GAS mice exhibited reduced concentrations of 5-HT in the PFC (F(1,8) = 4.0, p = 0.04; 825.37 ± 94.13, 
and 615.68 ± 45.96 ng/g tissue weight for CTRL and GAS respectively) and increased serotonin turnover 
(5-HIAA/5-HT ratio) in the cerebellum (F(1,8) = 4.8, p = 0.03; 1.16 ± 0.09 and 1.35 ± 0.06 for CTRL 
and GAS respectively). We then addressed whether these findings correlated with the behavioral data 
observed in the same individuals (see Table 3SM for details). With respect to 5-HT concentrations in 
the hippocampus, we observed that while they did not relate to behavior in the elevated 0-maze, they 
significantly correlated with several behavioral indices exhibited in the open field: frequency of cross-
ings (r2 = 0.50, p < 0.03); frequency of rearing (r2 = 0.52, p < 0.02); rearing duration (r2 = 0.60, p < 0.01); 
grooming duration (r2 = 0.65, p < 0.01). Additionally, although not significant, hippocampal serotonin 
apparently correlated with the latency to fall in the Dowel and Rotarod tests (r2 = 0.36, p = 0.06; r2 = 0.30, 
Figure 8. Sensorimotor gating measured through PPI (week 14, boost 3). Average inhibition of the startle 
reflex to a 120-dB stimulus following the presentation of a pre-pulse of different intensities (67, 70, 73, and 
76 dB). Values are expressed as mean percentage PPI (%PPI) + SEM. *p < 0.05. N = 8 per group.
Figure 9. Mean levels of the metabolite concentrations (expressed in mM) obtained from in vivo 1H 
spectra. (Upper panel) Striatum of CTRL and GAS groups. (Lower panel) Prefrontal cortex of CTRL and 
GAS groups. Data are expressed as mean ± SEM. *p < 0.05 in post-hoc tests performed between GAS and 
CTRL subjects. # p < 0.01 in non-parametric test performed between CTRL and GAS mice.
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p = 0.09). Finally, 5-HIAA/5-HT turnover was correlated with the rearing behavior exhibited in the ele-
vated 0-maze (r2 = 0.52, p < 0.02).
Immunohistochemistry. As reported in Fig. 10, histochemical and immunohistochemical investiga-
tions showed that, compared to CTRL mice, GAS mice exhibited indices of brain infiltrates (Chi2 = 3.26, 
N = 10, p < 0.05), associated with increased microglial activation (Chi2 = 3.06 N = 12, p < 0.05). In par-
ticular, scattered small inflammatory infiltrates (Fig.  10A,B), mainly containing CD3+ T lymphocytes 
(inset in Fig. 10A,B), were found in the white matter of the rostral and caudal diencephalon regions and 
more sporadically in the periventricular areas of GAS mice but not CTRL mice. Substantial increase in 
density of Iba1+ cells with morphology of ramified activated microglia has been detected both around 
the small inflammatory infiltrates (Fig.  10C) and, diffusely, across the white matter portion of both 
Figure 10. Neuropathology assessment of brains from GAS and CTRL mice. Panels (A,B) show 
inflammatory infiltrates (black arrows) in the white matter of the rostral diencephalon of two representative 
GAS mice, mainly containing CD3+ T lymphocytes (inset in (A,B)), not detected in the brains of control 
mice (C). Increased density of IBA1+ cells, morphologically resembling activated ramified microglia (inset 
in (E)), has been detected both around inflammatory infiltrates (D) and diffusely (E) in the mesencephalon 
of all the examined GAS mice, but not in the control mice (F). In some GAS mice, a group of IBA1+ 
activated microglia, forming a dense nodule, was found in the white matter in the rostral diencephalon ((G), 
higher magnification in (H)). Original magnification: 5X (A–C,G), 10X (D–F), 20X (inset in (E)), 40X (inset 
in (A,B)).
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diencephalon and mesencephalon regions of all of the 5 examined GAS mice (Fig.  10D), but not in 
the CTRL (Fig. 10E). Moreover, nodules of IBA1+ activated microglia were found in scattered areas of 
the white matter of the rostral diencephalon in several of the examined GAS mice, without evidence of 
presence of any inflammatory infiltrate (Fig. 10F,G).
Discussion
In the present study, we observed that repeated exposure of mice to a GAS homogenate, against which 
treated mice exhibited an antibody-mediated response, results in remarkable behavioral and neurological 
alterations. Thus, compared to control animals, GAS treated mice showed impaired sensorimotor gating, 
exhibited repetitive and perseverative behaviors at a higher rate, brain immunohistochemical and met-
abolic indicators of inflammatory processes, and alterations in monoamine concentrations. Importantly, 
the behavioral alterations were observed following repeated boosts and not in response to the first 
injection. This aspect, coupled with the immunohistochemical findings, strengthens the view that the 
observed phenotype may be associated with autoimmune responses to repeated exposure to GAS, that, 
in turn, target selected brain areas9,19. This hypothesis is substantiated by independent experimental 
evidence showing that serum obtained from GAS subjects reacts with rodent brain antigens and with 
human dopamine D1 and D2 receptor antigens3.
The behavioral alterations observed in GAS-treated mice are in accordance with the hypothesis that 
repeated exposure to streptococcus may relate to motor disturbances. Thus, the repetitive and per-
severative behaviors shown at an abnormal rate by GAS treated mice are homologous to symptoms 
observed in PANDAS (e.g. obsessive-compulsive behaviors, tics and impaired sensorimotor gating42,43). 
The marked increment in the frequency of rearing behavior displayed by GAS treated mice may resem-
ble human tics whereby it is invariant in its appearance, interrupts the regular behavioral routine, and 
is context-independent, as it is shown both in the elevated-0-maze and in the open field. Under normal 
conditions, rearing constitutes an explorative behavioral pattern regularly exhibited in a novel environ-
ment, which steadily declines with the progress of the experimental session44. However, when exhibited 
at an abnormal rate, such behavior may be the resultant of dysfunctional brain mechanisms. For exam-
ple, excess rearing behavior has been observed in lesion studies involving the basal ganglia45 and in 
pharmacological studies interfering with dopaminergic and serotonergic transmission46,47. Additionally, 
present data replicate previous observations conducted in response to repeated GAS exposure19,20. In our 
study, the possibility that rearing constitutes an abnormal pattern rather than a functional response to 
a novel environment is supported by the temporal distribution in which it has been observed. Thus, in 
the open field test, control animals generally display elevated levels of rearing behavior during the early 
phases of the test and not towards the end44. Conversely, GAS treated mice spontaneously exhibited this 
behavior even 45 minutes after the beginning of the test session. In contrast with previous literature20, 
reporting a deficit in motor coordination in GAS mice, we failed to observe major alterations on the 
rotarod between GAS and PBS mice. Although we cannot fully explain such discrepancy, we offer that 
it may be due to the fact that while in the present study we evaluated male mice, Yaddanapudi and col-
laborators (2010) tested both male and female subjects. Thus, previous studies demonstrated that male 
and female mice may show a differential susceptibility to experimental treatments modulating motor 
coordination48. Furthermore, this differential sensitivity to experimental treatments has been observed in 
SJL mice49. Finally, our data are apparently conflicting with those reported by3 who observed variations 
in grooming behavior in GAS-treated individuals. In this case, the inconsistency is most likely due to 
procedural differences: specifically, while we investigated spontaneous grooming, Brinberg and collab-
orators (2012) assessed this behavior in response to the puffing of misted water. Additional procedural 
differences include the use of Bordetella pertussis (present in Brinberg et al., 2012 and absent herein) and 
the experimental species (rats vs. mice).
Beside abnormal repetitive behavior, GAS treated mice exhibited an elevated rate of perseverative 
responses in the spontaneous alternation test. The spontaneous alternation, generally exhibited by con-
trol mice in this test, has been proposed to reflect a natural tendency to explore the entire environ-
ment34. Such behavior entails the integrity of several brain structures including prefrontal cortex and 
dorsal striatum50 and is sensitive to the administration of dopaminergic51 and serotonergic52 drugs. The 
deficit observed in sensorimotor gating constitutes additional evidence in support of the hypothesis 
that repeated exposure to GAS may result in a dysfunctional regulation of forebrain circuitry42,53. Thus, 
PPI in laboratory rodents is remarkably reduced by the experimental lesion of striatal circuits53,54, and 
is modulated by the administration of dopaminergic drugs55–59. Additionally, antipsychotics have been 
shown to modulate PPI in schizophrenic patients60,61 and healthy controls62. Based on neuroanatomi-
cal, pharmacological, and clinical evidence, PPI has been associated with several disturbances including 
schizophrenia, obsessive-compulsive disorders, and TS (see Ref. 42 for a review).
Finally, rather than reflecting a generalized response, the phenotype exhibited by GAS treated mice 
appears specific to repetitive and perseverative behavior. Thus, GAS and CTRL mice showed an indis-
tinguishable phenotype in anxiety-related tests, motor coordination and general locomotion. These con-
siderations appear to confer a sufficient degree of face validity (the phenomenological similarity between 
the phenotype of the experimental model and the human condition,63,64) to the experimental model 
presented herein18.
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Pharmacological, neuroanatomical, and brain imaging studies indicate that neurological distur-
bances characterized by impaired motor function are associated with dysfunctions at the level of sev-
eral brain structures and neurochemical pathways65. For example, TS generally involves abnormalities 
at the levels of the basal ganglia and several neurotransmitters66,67. While dopaminergic transmission 
has been associated with motor symptoms23, serotonin has been implicated both in motor inhibition 
and in obsessive-compulsive symptoms25,65. Based on this grounding, we predicted significant altera-
tions in dopaminergic and serotonergic circuitry. The reduced serotonin concentrations measured in 
the prefrontal cortex of GAS treated mice support our predictions and may further extend the validity 
of the proposed experimental model. Thus, this structure has been shown to modulate perseverative 
responding both in clinical68 and preclinical69,70 investigations. Additionally, altered serotonin concen-
trations may partly account for the motor alterations observed in the open field and elevated 0-maze 
tests. The involvement of the serotonergic system in the control of repetitive behavior has been demon-
strated through several experimental strategies. For example, several investigators demonstrated that the 
administration of selective 5-HT2 receptor agonists results in the exhibition of repetitive behaviors in 
mice22,71,72. Additionally, clinical data obtained through PET imaging indicate that TS patients exhibit 
elevated 5-HT2A receptor binding compared to healthy controls73. Furthermore, the observation that 
repeated GAS exposure altered brain neurochemistry in the cerebellum may provide additional support 
to the construct validity of the proposed model. Specifically, available literature suggests that the cere-
bellum is directly involved in spontaneous alternation50. For example, mutant mouse strains naturally 
exhibiting cerebellar atrophy have been shown to display deficits in spontaneous alternation74. Ultimately, 
experimental evidence indicates that serotonergic transmission may play a crucial role in modulating this 
domain in laboratory rodents50. Such evidence rests upon several studies conducted in rodents exposed 
to 5-HT receptor agonists75 or to a tryptophan deficient diet76. The role played by brain monoamines in 
modulating the behavioral phenotype is also partly substantiated by correlational evidence.
However, in contrast with our predictions and with previous literature3, we failed to observe significant 
alterations in dopaminergic transmission. With respect to rodent studies, we propose that differences in 
the species under analysis (rats in Refs. 3,21 and mice herein) and administration protocols may explain 
the discrepancy between our data and previous findings. Additionally, as cogently discussed by Buse and 
collaborators23 the relationship between dopamine and movement disorders is remarkably complex and, 
rather than being limited to differences in monoamine content, it may involve dopaminergic hyperin-
nervation, receptor sensitivity, and a dysfunction in the ratio between tonic and phasic activity23. Thus, 
future studies are needed to evaluate whether our experimental model presents analogous variations in 
the complex dopaminergic circuitry.
The autoimmune hypothesis behind our study poses that repeated peripheral exposure to GAS anti-
gens would elicit an antibody-mediated response (see above), increase the permeability of the blood 
brain barrier77, facilitate the transition of peripheral antibodies in the central nervous system78, and 
ultimately result in autoimmune phenomena targeting brain areas involved in motor control and per-
severative responding. These mechanisms were expected, in turn, to result in detectable inflammatory 
processes at the level of the cortico-striato-thalamo-cortical (CSTC) circuit42,79. To test this prediction, 
we adopted two complementary strategies. In a first batch of animals, we performed an in vivo magnetic 
resonance spectroscopy study in the striatum and prefrontal cortex of GAS treated and control mice. An 
independent set of mice were examined through immunohistochemistry to confirm that the behavioral, 
neurochemical, and metabolic abnormalities may be associated with antibody-mediated immune activa-
tion directed towards brain targets. In accordance with previous observations19,20, immunohistochemical 
assessment supported our original prediction by showing the presence of small inflammatory infiltrates 
and areas of diffuse microglia activation in all the examined GAS treated mice, in scattered areas of the 
rostral diencephalon controlling the behavioral domains addressed in the present study50. Additionally, 
in a subset of GAS treated mice, microglia nodules in normal appearing white matter, without evi-
dence of inflammatory infiltrates, have been detected. This finding suggests that chronic inflammatory 
conditions induced by repeated GAS exposures and following brain inflammation, including microglia 
activation, may play a key role in the brain alteration observed in the current animal model probably by 
producing cytokines and neurotoxins, such as NO and/or glutamate, that may directly mediate neuroin-
flammation and tissue damage.
The elevated concentrations of glutamate and glutamine, detected in the striatum of GAS treated 
mice, constitute further indirect evidence that inflammatory processes may have occurred in response 
to repeated exposure. Based on the regulatory role exerted by glutamatergic projections on the basal 
ganglia66, elevated levels of glutamate have been suggested to play a role in several psychiatric distur-
bances80,81. Furthermore, inflammatory processes have been shown to increase glutamate concentra-
tions in the basal ganglia in clinical studies conducted in a cohort of patients with hepatitis C82. The 
possibility that repeated GAS exposure resulted in inflammatory processes in TS-relevant brain areas 
is further substantiated by the elevated concentrations of lactic acid detected in the prefrontal cortex 
of GAS treated mice. Under physiological conditions, lactate constitutes the end product of anaerobic 
metabolism and, due to its physical properties, it is barely detectable in the brains of healthy experimen-
tal animals. Additionally, lactate concentrations vary depending on the specific brain area, and attain 
highest values in the striatum and smallest in cerebral cortex, with fluctuations due to nutritional state 
and anesthesia83,84. Due to its low level, lactate has been detected, in rodent brain cortex, only at magnetic 
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fields higher than 9.4 T. Pathological conditions and inflammatory processes may affect the balance of 
anaerobic metabolism ultimately increasing lactate concentrations85. In accordance with these predic-
tions, lactate concentrations were remarkably elevated in the prefrontal cortex of GAS treated mice and 
were not detected in control subjects. Since all subjects were submitted to the same dietary and anesthetic 
regimen, we suggest that the increase in lactate observed in the GAS group was due to the presence of 
inflammatory process. Although hypothetical, in accordance with Belanger and collaborators86, it may be 
tenable that the alterations observed in striatum and PFC reflect a functional interaction between these 
metabolites. Specifically, the authors proposed the existence of a mechanistic link (involving aerobic 
glycolysis) between glutamate release occurring in neurons, and extracellular lactate release dependent 
on astrocytes86. Finally, we failed to observe differences in lactate concentrations between GAS and con-
trol subjects in the striatum. Although hypothetical, we suggest that since lactate concentrations in the 
striatum are naturally higher compared to other brain structures83,84, potential ceiling effects may have 
masked underlying inflammatory processes.
In the present study, we strengthened the feasibility of an experimental model suited for the study of 
PANDAS. Additionally, the fact that the behavioral abnormalities are observed following repeated boosts, 
and not in response to the first immunization, indirectly supports the view that the exhibition of the 
pathological phenotype requires prolonged processes and high antibody levels to occur. This view is fur-
ther supported by the observation that antibodies in serum were observed only in response to repeated 
boosts and not after the first immunization. This may also account for the fact that the development of 
the abnormal behavioral and neurological phenotype may entail gradual autoimmune responses directly 
targeting relevant neuroanatomical pathways. This hypothesis is in line with the immunohistochemical 
and MRS evaluations conducted in the brain areas putatively involved in the regulation of repetitive and 
perseverative behaviors. It is plausible that the GAS antigen/s responsible for the observed phenotype 
resides among the several proteins detected in treated animals. However, the identification of the precise 
antigen/s awaits future experiments wherein mice will be injected with single antigens in place of whole 
homogenates.
An additional limitation of the present study regards the timing of evaluation of the phenotype asso-
ciated with streptococcus administration. As discussed in the introduction, the acronym PANDAS con-
notes a series of disturbances occurring in the pediatric population. Yet, both the present study and 
those conducted within the same theoretical framework19,20, have investigated young adult individuals. 
The principal reason for this limitation resides in technical constraints associated with the immunization 
protocol. To adequately mimic a disturbance associated with repeated exposure to streptococcus, the pro-
tocol necessitates several injections which, in turn, require some time to stimulate a complete immune 
response. Based on these constraints, and in accordance with previous literature, we deemed necessary 
to interspace the injections by three weeks. Thus, the effects of repeated exposures to streptococcus were 
assessed in young adult individuals. Nonetheless, the primary role played by an infantile immune sys-
tem was addressed by beginning the injection protocol as early as PND 28 (i.e. before puberty). Future 
studies shall investigate whether the phenomena proposed herein can be observed in younger individ-
uals. To address this possibility, it is tenable to propose a differential administration protocol entailing 
shorter between-boost intervals (e.g. two weeks) and an earlier timing of first injection (e.g. PND 21). 
Furthermore, to confirm that these processes are specifically dependent on exposures occurring during 
early maturational stages, future studies shall test the hypothesis that immunization procedures per-
formed in adult individuals, are less efficient than identical procedures performed earlier in development.
Despite the aforementioned limitations, we believe that this study may inform future research from two 
complementary perspectives: (i) from a theoretical perspective, it gives support to the immune-mediated 
hypothesis of disorders like SC and TS, thereby allowing the analysis of novel prophylactic and thera-
peutic strategies aimed at preventing GAS colonization/infection in early infancy; (ii) from a preclinical 
perspective, the development of a mouse model possessing elevated construct and face validity may be 
leveraged to investigate the regulatory role exerted by the environment (e.g. psychosocial stress, difficult 
pregnancy, maternal smoking) in modulating the exhibition of symptoms. Moreover, a more detailed 
analysis of inflammatory events occurring in the brain of GAS mice may help clarifying the precise cell 
and molecular mechanisms involved in the neuropathology of the current experimental model.
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